We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Launching Full-Scale Sentinel System for Drug Safety Investigations
FDA Launching Full-Scale Sentinel System for Drug Safety Investigations
The FDA in 2015 plans to begin work on a nationwide network of electronic health records and insurance claims data it will use to investigate drug safety questions that emerge from adverse event reports or other sources.